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Abstract 
We report the first pilot qualitative confocal microscopic analysis of a laser in situ kera-
tomileusis (Lasik) treatment combined with sequential high-fluence accelerated corneal 
collagen cross-linking, denominated Lasik XTra, by means of HRT II laser scanning in vivo 
confocal microscopy after a 6-month follow-up. After obtaining approval from the Siena 
University Hospital Institutional Review Board, a 33-year-old female patient underwent a 
Lasik XTra procedure in her left eye. Confocal analysis demonstrated induced slight corneal 
microstructural changes by the interaction between UV-A, riboflavin and corneal stromal 
collagen, beyond the interface to a depth of 160 µm, without adverse events at the interface 
and endothelial levels. This application may be considered a prophylactic biomechanical 
treatment, stiffening the intermediate corneal stroma to prevent corneal ectasia and 
stabilizing the clinical results of refractive surgery. According to our preliminary experiences, 
this combined approach may be useful in higher-risk Lasik patients for hyperopic treatments, 
high myopia and lower corneal thicknesses. © 2014 S. Karger AG, Basel 
Introduction 
Corneal collagen cross-linking treatment demonstrated a long-term efficacy in the 
treatment of primary and secondary (post-Lasik and post-RK) corneal ectasias [1, 2]. 
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Confocal microscopy studies in standard and accelerated corneal collagen cross-linking 
showed that the penetration of the treatment, estimated on keratocyte apoptosis, is 
inversely proportional to UV-A power (the higher UV-A power produces lower penetration) 
and directly proportional to exposure time (the longer UV-A exposure time produces higher 
penetration) [3, 4]. 
Recently, accelerated corneal collagen cross-linking with high fluence was performed 
concurrently with laser in situ keratomileusis (Lasik) in a small group of patients in order to 
prevent corneal ectasia after Lasik treatment, reporting good clinical results [5]. It was also 
applied to prevent regression in post-Lasik hyperopic and high myopia treatments. The 
results in these pilot case series suggest that an evaluation of a larger study cohort is 
warranted to establish the utility of this treatment [6, 7]. 
Kanellopoulos and Asimellis [8] recently published 43 consecutive sequential Lasik plus 
accelerated corneal collagen cross-linking procedures. All eyes at the completion of Lasik 
had cross-linking through the repositioned flap, with higher fluence (10 mW/cm2 UV-A light 
of an average of 370 μm wavelength) applied for 3 min following an earlier single instillation 
of 0.1% riboflavin within the flap interface. The average follow-up duration was 3.5 (range 
1.0–4.5) years. The authors concluded that prophylactic collagen cross-linking for high-risk 
Lasik cases appeared to be a safe and effective adjunctive treatment for refractive regression 
and potential ectasia. 
According to preliminary literature [9], this combined application may be viewed as 
prophylactic customization of the biomechanical behavior of corneal collagen. More recently 
the same author reported good results by using Avedro’s KXL I device (Waltham, Mass., USA) 
at the higher UV-A power of 30 mW/cm2, for a total of 80 s, in order to achieve a stromal 
collagen cross-linking [9]. 
Here, we report a pilot qualitative confocal microscopic study on a patient undergoing 
Lasik combined with sequential accelerated corneal collagen cross-linking (Lasik XTra) by 
means of HRT II laser scanning in vivo confocal microscopy after a 6-month follow-up. 
Case Report 
After approval by the Siena University Hospital Review Board and a specific-informed 
consent signature, a 33-year-old female patient underwent a Lasik XTra procedure (Lasik 
combined with sequential high-fluence cross-linking) in her left eye. Treatment parameters 
of the left partially amblyopic eye were: –5 dpt of myopia with a corrected distance visual 
acuity of 20/40. Her fellow eye (right) had 20/20 uncorrected distance visual acuity. 
Preoperative optical pachymetry of the treated eye was 530 µm in the thinnest point. 
Endothelial cell count was 2,770 cells/mm2. The preoperative ideal pupil diameter was 6 
mm (C.S.O. Eye Top Pupillometer, Florence, Italy). The preoperative corneal topography was 
within normal limits. 
The Lasik procedure (fig. 1) was performed by the IntraLaseTM FS Laser (Abbott Medical 
Optics Inc., AMO Santa Ana, Calif., USA). A 95-µm-thick flap was programmed with superior 
nasal hinge; after Lasik cut and flap lifting, the excimer laser treatment was performed by a 
Technolas 217z, 100-Hz Excimer Laser (Bausch and Lomb), setting the following parame-
ters: –5 dpt of myopia with a 6.4-mm optical zone and tissue-saving algorithm (Zyoptix). 
After excimer laser treatment, the corneal stroma was soaked with a riboflavin 0.25% saline 
solution for 90 s (VibeX Xtra, Avedro, Waltham, Mass., USA), then the surface was rinsed with 
a balanced salt solution, the flap repositioned and UV-A irradiation applied over the 
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epithelial surface for 90 s of continuous light illumination at 30 mW/cm2 (energy dose of 2.7 
J/cm2) according to Avedro’s Lasik Xtra protocol. 
After UV-A radiation the cornea was medicated with antibiotic (ciprofloxacin) and non-
steroidal anti-inflammatory eyedrops (diclofenac). In vivo HRT II scanning laser confocal 
analysis was performed 1 week, 3 and 6 months after treatment. The postoperative in vivo 
micromorphological analysis (fig. 2) revealed the following: the epithelium (fig. 2a) showed 
slight alterations due to UV-A radiation, demonstrating areas of missing cells in the first 15 
days after treatment. At 1, 3 and 6 months, the epithelial healing and cell stratification was 
within the normal limits. Nerves showed a rarefaction of subbasal and subepithelial fibers 
after UV-A radiation. Even if subjected to slight damage, the subepithelial fibers did not 
disappear after Lasik Xtra as shown in a confocal scan (fig. 2b). 
Stromal healing demonstrated a slight microlacunar edema that was present in the first 
month after treatment into the flap’s stroma up to 100 µm of depth; spared keratocyte nuclei 
were detected with increased reflectivity (cell activation) into the flap upon the interface, as 
shown in confocal scans (fig. 2c, d). 
The interface was hypocellular and well-distinguished, containing numerous hyperre-
flective microspots or bright particles as revealed by confocal images (fig. 2e, f). 
The stroma beyond the interface demonstrated relevant interactions between UV-A, 
riboflavin and corneal collagen (fig. 2g) with evident keratocyte apoptosis, documented by 
rarefaction of keratocyte nuclei and diffuse edema, until a depth of 60 µm over the interface, 
where the apoptotic phenomena ended, resembling the normal appearance of the stroma 
shown as well in fig. 2h and i. The intermediate stroma beyond 160 µm and the deep stroma 
were unreached by the combined photoablative, photodisruptive and photooxidative 
damage, as documented by the presence of normal keratocyte nuclei (fig. 2j, l). 
Corneal endothelium examined in the first 15 days after treatment showed an area of 
missing cells similar to guttae (fig. 2l) suspecting a potential hot-spot area induced by high-
intensity UV-A power or related to poor corneal thickness. However, this aspect disappeared 
during the follow-up and might also be interpreted as possible early artifact due to stromal 
edema. Indeed no changes in endothelial cell count (2,739 cells/mm2 at the 6th month) were 
recorded during the follow-up and the endothelium assumed a slight pleomorphic appear-
ance as shown in fig. 3. 
Discussion 
Confocal microscopy performed after Lasik Xtra enables us to assess the microstructural 
changes induced by the treatment from epithelium to endothelium. 
Epithelial basal cells showed an immediate slight damage related to a direct cytotoxic 
effect of UV-A irradiation; however, the epithelium appeared normal in the first month after 
treatment. The natural shielding effect provided by the epithelium itself [9–12], not soaked 
with riboflavin, absorbs about 25% of UV-A rays. 
After Lasik Xtra, the nerve fibers of the subepithelial plexus did not disappear. Only a 
slight nerve rarefaction was recorded, reasonably due to femtosecond laser flap sculpture 
(applanation and photodisruption) and less to UV-A radiation. Stromal nerves disappeared 
reasonably due to flap femtosecond laser sculpture and excimer laser photoablation. 
Keratocyte apoptosis into the flap was poor and associated with a slight and diffuse 
stromal edema reaching the wound interface. The interface plane was found at about 100 
µm, appearing markedly hypocellular with numerous hyperreflective bright particles; 
soaking with the riboflavin solution may require a longer interface washing to avoid the 
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permanence of detritus, or the surgeon should lift the flap rewashing the stromal plane at 
the end of the procedure. Spared keratocyte activation into the flap upon the interface may 
be related to UV-A toxicity while beyond the interface we did not observe any cell activation. 
Keratocyte apoptosis, indeed, was maximum beyond the wound interface reaching a depth 
of 150–160 µm. The alterations in corneal stroma underlying the interface can be caused by 
the combined effect of photodisruption (femtosecond laser), photoablation (excimer laser), 
and photooxidative damage (UV-A cross-linking). Confocal microscopy analysis after 
standard femto-Lasik treatments for myopia revealed that keratocytes tend to disappear 
around the wound interface but, at the same time, other keratocytes show activation [13]. 
Conversely, in this confocal analysis, keratocyte apoptosis and corneal edema were present 
beyond the interface, without fibrosis and activated keratocyte nuclei. The presence of a 
more evident corneal edema, without keratocyte activation, may reasonably depend on 
adjunctive interactions between riboflavin molecules, UV-A photons and stromal collagen 
that mainly occur from the interface plane (not into the flap) until a depth of 50–60 µm of 
corneal stroma beyond the interface in femto-Lasik with adjunctive high-fluence UV-A cross-
linking. Indeed, over 160 µm of stromal depth, measured from the epithelial surface, there 
are no appreciable changes. 
During the follow-up, corneal edema disappeared gradually and keratocyte repopula-
tion was complete at the 6th month. No changes in the density of the extracellular matrix, 
nor evidence of stromal nerve regeneration were recorded at the 6th month. 
At present, we do not exactly know the utility of a widely used prophylactic combination 
between Lasik and sequential accelerated cross-linking, even if this study demonstrated no 
adverse events on the corneal interface, stroma and endothelium. According to preliminary 
experiences, the Lasik Xtra may determine a reasonable biomechanical stiffening of the 
intermediate stroma beyond the interface and a strongest adherence between the flap and 
the corneal stroma (glue effect) [14]. 
A large cohort of patients is needed to determine the clinical significance and the utility 
of this combined refractive surgical therapy. Our patient was well 6 months after treatment, 
reporting an uncorrected distance visual acuity of 20/40. In our opinion this combined 
approach may be qualitative in the field of refractive surgery and reasonably effective in 
treating higher-risk Lasik patients such as hyperopic, high myopic patients and those with 
lower corneal thickness (under 500 µm). 
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Fig. 1. a Lasik Xtra: after flap lifting and excimer laser treatment, the corneal stroma is soaked by 
riboflavin 0.25% saline solution (VibeX Xtra) for 90 s. b After 90 s of riboflavin soaking, the corneal 
surface is washed with balanced salt solution and the flap repositioned. Then, accelerated high-fluence 
corneal collagen cross-linking was performed at 30 mW/cm2 for 90 s of UV-A exposure. c The final aspect 
of the cornea at the end of the treatment is shown. 
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Fig. 2. Confocal microscopy overview in the first week after Lasik Xtra. a Undamaged basal epithelium.  
b Subepithelial plexus fibers did not disappear after treatment (arrow). c, d Slight keratocyte apoptosis 
associated with edema into the corneal flap before Lasik interface (arrow). e, f Lasik interface with bright 
hyperreflective particles (arrows). g Keratocyte apoptosis and increased edema beyond the interface until 
150 µm showing the area of maximum photooxidative impact, i.e. maximum riboflavin UV-A-collagen 
interaction (asterisk). h, i Vertical transition area delimiting the end of photooxidative damage and 
apoptosis at 160 µm, i.e. riboflavin UV-A interaction (white arrows). j Intermediate stroma unreached by 
photooxidative damage, i.e. riboflavin UV-A interaction. k Deep stroma unreached by photooxidative 
damage, i.e. riboflavin UV-A interaction. l Corneal endothelium showing a circular area of pseudo-guttae 
(arrow). 
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Fig. 3. Corneal endothelium at 1 (a), 3 (b), 6 (c) months after Lasik Xtra showing cell pleomorphism. No 
significant endothelial cell loss was established after treatment. 
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